 |
|
Monory K, Massa F, Egertová M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch R, Ekker M, Long J, Rubenstein JL, Goebbels S, Nave KA, During M, Klugmann M, Wölfel B, Dodt HU, Zieglgänsberger W, Wotjak CT, Mackie K, Elphick MR, Marsicano G, Lutz B.
The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron.
2006 Aug 17;51(4):455-66.
PubMed Abstract
|
|
|
|
|
|
|
Comments on Paper and Primary News |
|
|
| |
Primary News: Endocannabinoids: Wet Blanket on Hippocampus Excitement
Comment by: Olorunyomi Olowosegun
|
|
|
Submitted 29 August 2006
| Permalink
|
Posted 29 August 2006
|
|
|
I think it would be worthwhile to look at the brain of older people who have used marijuana chronically and compare it with the brain of age-matched people who never used it. This simple comparison could throw added light on whether cannabis could help people with Alzheimer disease.  View all comments by Olorunyomi Olowosegun |
|
|
| |
Primary News: Endocannabinoids: Wet Blanket on Hippocampus Excitement
Comment by: Kiumars Lalezarzadeh
|
|
|
Submitted 4 September 2006
| Permalink
|
Posted 5 September 2006
|
|
|
 I recommend this paper
The research is very interesting and important. In Los Angeles, California, use of medical cannabis is encountered working in the field with adolescents or young adults. There is indeed controversy since hidden side effects include perceptual and family disorders. Those also need consideration at the psychosocial level.
At the neuronal level, cannabinoid research also needs to rule out an effect of cannabinoids on reducing prion fibrils (see Colin et al., 1999) or neurogenesis (La Spada, 2005). Neuroendocrine effects, prolactin release, gonadal atrophy, and tumor genesis need attention when studying cannabinoids.
References:
Combs CK, Johnson DE, Cannady SB, Lehman TM, Landreth GE. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins.
J Neurosci. 1999 Feb 1;19(3):928-39.
Abstract
La Spada AR. Huntington's disease and neurogenesis: FGF-2 to the rescue?
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):17889-90. Epub 2005 Dec 5. No abstract available.
Abstract
View all comments by Kiumars Lalezarzadeh |
|
|
| |
Primary News: Endocannabinoids: Wet Blanket on Hippocampus Excitement
Comment by: Kiumars Lalezarzadeh
|
|
|
Submitted 7 September 2006
| Permalink
|
Posted 9 September 2006
|
|
|
I recommend this paper
Cannabinoid agonist is shown to have a thermal hyperalgesia effect in inflammatory pain involving the sensory pathways and activation of the calcineurin (Nathaniel et al., 2006). The role of sensory inhibition, anhedonia, and known effects of calcineurin in psychosis also need consideration.
References: Nathaniel A. Jeske, Amol M. Patwardhan, Nikita Gamper, Theodore J. Price, Armen N. Akopian, and Kenneth M. Hargreaves (2006, September 5). Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons. J. Biol. Chem, 10.1074/jbc.M603220200
View all comments by Kiumars Lalezarzadeh |
|
|
| |
Submit a Comment on this Paper |
|
|
|
|
| |
 |
|
| |
|
|
|
|
Home
